The increase in average price targets by analysts suggests a more optimistic outlook for GeneDx Holdings. The company's strong revenue growth supports this positive sentiment. However, challenges in profitability and asset utilization may temper the enthusiasm. Overall, the short-term impact is likely positive due to the raised price targets and revenue growth.